Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

autologous anti-CD83 CAR T cells

A preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting CD83, with potential antineoplastic activity. Upon administration, autologous anti-CD83 CAR T cells recognize and kill CD83-expressing tumor cells. CD83 is expressed on acute myeloid leukemia (AML) blasts.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:autologous anti-CD83 CAR-T cells
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search